🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

James M. Rae

University of Michigan

ORCID: 0000-0002-3412-8219

Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10527

Top 100%

0DataRank

Top 100%0 citations

Yi‐Mi Wu, Dan R. Robinson, James M. Rae, N. Lynn Henry, Daniel F. Hayes +9 more

Papers

Driven by 16 papers — median percentile 0. Top paper: “Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)”.

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)

Biomarkers(2023)10.1080/1354750x.2023.2168063

N/A

0.587DataRank · unranked

12 citations

Adrian Nordmark, Amy Williams, Costanza Paoletti, William E. Barlow, Erin F. Cobain +11 more

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1562

N/A

0.457DataRank · unranked

20 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10527

Top 100%

0DataRank

Top 100%0 citations

Yi‐Mi Wu, Dan R. Robinson, James M. Rae, N. Lynn Henry, Daniel F. Hayes +9 more

Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms

Research Square(2022)10.21203/rs.3.rs-1315678/v1

N/A

0DataRank · unranked

5 citations

Julie A. Douglas, Robert M. Miller, Kelley M. Kidwell, Christina L. Gersch, Zeruesenay Desta +7 more

Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00136

N/A

0DataRank · unranked

96 citations

J. Thomas, Ranjan Kumar Acharyya, James M. Rae, Shaomeng Wang, Rohan Kalyan Rej

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384.v1

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Data from Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

(2023)10.1158/1078-0432.c.6523959

N/A

0DataRank · unranked

0 citations

Amanda L. Blackford, Anne Nguyen, Todd C. Skaar, Santosh Philips, Steffi Oesterreich +12 more

Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1076

N/A

0DataRank · unranked

0 citations

William E. Barlow, Costanza Paoletti, Mattias Bergqvist, Amy Williams, Hanna Ritzén +11 more

Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01521

N/A

0DataRank · unranked

21 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more

Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation

JAMIA Open(2024)10.1093/jamiaopen/ooae006

N/A

0DataRank · unranked

1 citations

Vered Stearns, Amanda L. Blackford, Daniel L. Hertz, Karen L. Smith, James M. Rae +2 more

Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling

Neoplasia(2025)10.1016/j.neo.2025.101190

N/A

0DataRank · unranked

2 citations

Caroline Bishop, Cydnee Wilson, Meilan Liu, Kalli R. Jungles, Kari Wilder-Romans +4 more

Factors Associated With the Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Left Ventricular Dysfunction

Journal of Cardiovascular Pharmacology and Therapeutics(2025)10.1177/10742484241304304

N/A

0DataRank · unranked

2 citations

Tk Nguyen, Xuesi Hua, Blair Richards, James M. Rae, Robert T. Dess +6 more

Genetic Variation in Charcot–Marie–Tooth Genes Contributes to Sensitivity to Paclitaxel-Induced Peripheral Neuropathy

Pharmacogenomics(2020)10.2217/pgs-2020-0053

N/A

0DataRank · unranked

14 citations

Fang Fang, Kelley M. Kidwell, Kiran Vangipuram, Lauren A. Marcath, Christina L. Gersch +7 more

Correction to “Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer”

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00592

N/A

0DataRank · unranked

1 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more

Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer

Frontiers in Genetics(2021)10.3389/fgene.2021.662734

N/A

0DataRank · unranked

14 citations

Karen L. Smith, Yuhua Zong, Christina L. Gersch, Andrea M. Pesch, Jennifer Lehman +6 more